Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis
Stephen D. Smith, Paolo Lopedote, Yazeed Samara, Matthew Mei, Alex F. Herrera, Allison Winter, Brian T. Hill, Mazyar Shadman, Chaitra S. Ujjani, Ryan C. Lynch, Caron A. Jacobson, Austin I. Kim, Paolo F. Caimi, Filippo Milano, Ajay K. Gopal
Topics & Concepts
MedicineRefractory (planetary science)Internal medicineBendamustineDiscontinuationRituximabSalvage therapyLymphomaGastroenterologyClinical trialNeutropeniaOncologySurgeryToxicityChemotherapyAstrobiologyPhysicsLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders researchHER2/EGFR in Cancer Research